INVESTOR FAQs

Where is NuGenerex Immuno-Oncology’s (NuGenerex) corporate headquarters?

NuGenerex Immuno-Oncology
10102 USA Today Way
Suite 200
Miramar, FL
33025

Where is the Company incorporated?

NuGenerex is incorporated in Delaware

When did NuGenerex become a public company?

NuGenerex became a public company in May 2020

What exchange does NuGenerex trade on and what is the Company’s ticker symbol?

The Company has applied to list its shares on the NASDAQ Capital Market, under the ticker symbol NGIO.

When is NGIO’s fiscal year-end?

July 31

Who is NGIO’s transfer agent?

Securities Transfer Corporation (STC)
2901 N Dallas Parkway
Suite 380
Plano, Texas 75093
(469) 633-0101

Whom do I contact with questions about my stock and how do I transfer, change address on my account or replace a lost stock certificate?

Please contact our transfer agent, Securities Transfer Corporation (STC).

Who is NGIO’s legal counsel and auditor?

Legal Counsel:
Jeffrey P. Wofford, Esq.
Carmel, Milazzo & Feil LLP
55 West 39th Street, 18th Floor
New York, New York 10018

Auditor:
Mazars, LLP
215 St Jacques St.
Montreal, QC H2Y 1M6
Canada

Who can I call for investor related questions?

Please refer to our IR Contact page in the Investors section of our website.